Browse > Article
http://dx.doi.org/10.5392/JKCA.2018.18.12.208

Cardiovascular Risk Factors in Diabetic Patients according Duration of Diabetes Mellitus: The Sixth Korea National Health and Nutrition Examination Survey  

Kim, Hee Sung (단국대학교 의과대학 제일병원 진단검사의학과)
Publication Information
The Journal of the Korea Contents Association / v.18, no.12, 2018 , pp. 208-217 More about this Journal
Abstract
The purpose of this study was to provide information on the treatment and management of diabetic patients using all the available data of the Korea National Health and Nutrition Examination Survey (KNHANES, 2013-2015) on the serological and complication patterns of cardiovascular disease (CVD) according to the duration of diabetes mellitus (DM). KNHANES consists of health questionnaires, screenings, and nutrition surveys. The study subjects were 1,316 persons who were aged between 18 and 80 years and who answered the duration of DM. DM was classified as 0-5, 6-10, 11-15, 16-20, and over 20 years according to duration of DM. The longer the duration of DM, the older the BMI, the lower the smoker, the higher the HbA1c and the lower the glomerular filtration rate. Total cholesterol, LDL-C and triglyceride levels were low and HDL-C levels were similar. The proportion of patients receiving insulin and oral hypoglycemic agents increased. The longer the duration of DM, the worse blood glucose control and the increased risk of microvascular and macrovascular complications. To prevent these complications, intensive care and monitoring should be used to control the risk factors.
Keywords
Diabetes Complication; Cardiovascular Risk Factors; Diabetes Mellitus Duration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 S. Rao Kondapally Seshasai, S. Kaptoge, A. Thompson, E. Di Angelantonio, P. Gao, N. Sarwar, P. H. Whincup, K. J. Mukamal, R. F. Gillum, I. Holme, I. Njolstad, A. Fletcher, P. Nilsson, S. Lewington, R. Collins, V. Gudnason, S. G. Thompson, N. Sattar, E. Selvin, F. B. Hu, J. Danesh, and C. Emerging Risk Factors, "Diabetes mellitus, fasting glucose, and risk of cause-specific death," N Engl J Med, Vol.364, No.9, pp.829-841, 2011.   DOI
2 C. Centers for Disease and Prevention, "Prevalence of self-reported cardiovascular disease among persons aged > or =35 years with diabetes-United States, 1997-2005," MMWR Morb Mortal Wkly Rep, Vol.56, No.43, pp.1129-1132, 2007.
3 Korea National Health and Nutrition Examination Survey, https://knhanes.cdc.go.kr/knhanes/sub03/sub03_02_02.do
4 A. American Diabetes, "Standards of medical care in diabetes-2015 abridged for primary care providers," Clin Diabetes, Vol.33, No.2, pp.97-111, 2015.   DOI
5 J. A. Beckman, M. A. Creager, and P. Libby, "Diabetes and atherosclerosis: epidemiology, pathophysiology, and management," JAMA, Vol.287, No.19, pp.2570-2581, 2002.   DOI
6 J. Y. Jeon, S. H. Ko, H. S. Kwon, N. H. Kim, J. H. Kim, C. S. Kim, K. H. Song, J. C. Won, S. Lim, S. H. Choi, M. J. Jang, Y. Kim, K. Oh, D. J. Kim, B. Y. Cha, and A. Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes, "Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c," Diabetes Metab J, Vol.37, No.5, pp.349-357, 2013.   DOI
7 C. A. Reasner, "Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors," J Cardiovasc Pharmacol, Vol.52, No.2, pp.136-144, 2008.   DOI
8 A. J. Hahr and M. E. Molitch, "Management of diabetes mellitus in patients with chronic kidney disease," Clin Diabetes Endocrinol, Vol.1, p.2, 2015.   DOI
9 P. A. James, S. Oparil, B. L. Carter, W. C. Cushman, C. Dennison-Himmelfarb, J. Handler, D. T. Lackland, M. L. LeFevre, T. D. MacKenzie, O. Ogedegbe, S. C. Smith Jr., L. P. Svetkey, S. J. Taler, R. R. Townsend, J. T. Wright Jr., A. S. Narva, and E. Ortiz, "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)," JAMA, Vol.311, No.5, pp.507-520, 2014.   DOI
10 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)," JAMA, Vol.285, No.19, pp.2486-2497, 2001.   DOI
11 A. Gottsater, A. R. Ahlgren, S. Taimour, and G. Sundkvist, "Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes," Clin Auton Res, Vol.16, No.3, pp.228-234, 2006.   DOI
12 S. Natarajan, Y. Liao, D. Sinha, G. Cao, D. L. McGee, and S. R. Lipsitz, "Sex differences in the effect of diabetes duration on coronary heart disease mortality," Arch Intern Med, Vol.165, No.4, pp.430-435, 2005.   DOI
13 S. G. Wannamethee, A. G. Shaper, P. H. Whincup, L. Lennon, and N. Sattar, "Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors," Arch Intern Med, Vol.171, No.5, pp.404-410, 2011.   DOI
14 E. B. Schroeder, L. E. Chambless, D. Liao, R. J. Prineas, G. W. Evans, W. D. Rosamond, G. Heiss, and S. Atherosclerosis Risk in Communities, "Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study," Diabetes Care, Vol.28, No.3, pp.668-674, 2005.   DOI
15 A. I. Adler, R. J. Stevens, S. E. Manley, R. W. Bilous, C. A. Cull, R. R. Holman, and G. Ukpds, "Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)," Kidney Int, Vol.63, No.1, pp.225-232, 2003.   DOI
16 D. Orozco-Beltran, V. F. Gil-Guillen, F. Quirce, J. Navarro-Perez, M. Pineda, A. Gomez-dela- Camara, S. Pita, J. Diez-Espino, J. Mateos, J. Merino, M. Serrano-Rios, and I. Collaborative Diabetes Study, "Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain," Int J Clin Pract, Vol.61, No.6, pp.909-915, 2007.   DOI
17 F. P. Schena and L. Gesualdo, "Pathogenetic mechanisms of diabetic nephropathy," Journal of the American Society of Nephrology, Vol.16, No.3, Suppl.1, pp.S30-S33, 2005.   DOI
18 M. J. Fowler, "Microvascular and macrovascular complications of diabetes," Clinical diabetes, Vol.26, No.2, pp.77-82, 2008.   DOI
19 F. A. El-Atat, S. N. Stas, S. I. McFarlane, and J. R. Sowers, "The relationship between hyperinsulinemia, hypertension and progressive renal disease," Journal of the American Society of Nephrology, Vol.15, No.11, pp.2816-2827, 2004.   DOI
20 P. J. Boyle, "Diabetes mellitus and macrovascular disease: mechanisms and mediators," Am J Med, Vol.120, No.9, Suppl.2, pp.S12-17, 2007.   DOI
21 M. Sakamoto, "Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice," J Clin Med Res, Vol.10, No.10, pp.737-742, 2018.   DOI
22 M. Brownlee, "Glycation products and the pathogenesis of diabetic complications," Diabetes Care, Vol.15, No.12, pp.1835-1843, 1992.   DOI
23 F. B. Hu, M. J. Stampfer, C. G. Solomon, S. Liu, W. C. Willett, F. E. Speizer, D. M. Nathan, and J. E. Manson, "The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up," Archives of internal medicine, Vol.161, No.14, pp.1717-1723, 2001.   DOI
24 L. E. Garcia-Perez, M. Alvarez, T. Dilla, V. Gil-Guillen, and D. Orozco-Beltran, "Adherence to therapies in patients with type 2 diabetes," Diabetes Ther, Vol.4, No.2, pp.175-194, 2013.   DOI
25 R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, B. Kassai, S. Erpeldinger, J. M. Wright, F. Gueyffier, and C. Cornu, "Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: metaanalysis of randomised controlled trials," BMJ, Vol.343, p.d4169, 2011.   DOI
26 W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, P. D. Reaven, F. J. Zieve, J. Marks, S. N. Davis, R. Hayward, S. R. Warren, S. Goldman, M. McCarren, M. E. Vitek, W. G. Henderson, G. D. Huang, and V. Investigators, "Glucose control and vascular complications in veterans with type 2 diabetes," N Engl J Med, Vol.360, No.2, pp.129-139, 2009.   DOI
27 W. B. Kannel, "Lipids, diabetes, and coronary heart disease: insights from the Framingham Study," Am Heart J, Vol.110, No.5, pp.1100-1107, 1985.   DOI
28 R. M. Krauss and P. W. Siri, "Dyslipidemia in type 2 diabetes," Med Clin North Am, Vol.88, No.4, pp.897-909, 2004.   DOI
29 S. J. Hamilton and G. F. Watts. "Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment," Rev Diabet Stud, Vol.10, No.2-3, pp.133-156, 2013.   DOI
30 Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults, "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary," Am J Clin Nutr, Vol.68, No.4, pp.899-917, 1998.   DOI
31 E. J. Lamb, C. R. Tomson, P. J. Roderick, and B. Clinical Sciences Reviews Committee of the Association for Clinical, "Estimating kidney function in adults using formulae," Ann Clin Biochem, Vol.42, No.Pt 5, pp.321-345, 2005.   DOI
32 Korean Statistical Information Service, http://www.kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_11702_N102
33 V. Patney, A. Whaley-Connell, and G. Bakris, "Hypertension Management in Diabetic Kidney Disease," Diabetes Spectr, Vol.28, No.3, pp.175-180, 2015.   DOI
34 E. Szoke, M. Z. Shrayyef, S. Messing, H. J. Woerle, T. W. van Haeften, C. Meyer, A. Mitrakou, W. Pimenta, and J. E. Gerich, "Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance," Diabetes Care, Vol.31, No.3, pp.539-543, 2008.   DOI
35 D. J. Margolis, O. Hoffstad, and B. L. Strom, "Association between serious ischemic cardiac outcomes and medications used to treat diabetes," Pharmacoepidemiol Drug Saf, Vol.17, No.8, pp.753-759, 2008.   DOI
36 J. M. Gamble, S. H. Simpson, D. T. Eurich, S. R. Majumdar, and J. A. Johnson, "Insulin use and increased risk of mortality in type 2 diabetes: a cohort study," Diabetes Obes Metab, Vol.12, No.1, pp.47-53, 2010.   DOI
37 R. Lajara, R. Aguilar, U. Hehnke, H. J. Woerle, and M. von Eynatten, "Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials," Clin Ther, Vol.36, No.11, pp.1595-1605, 2014.   DOI